(Q36295058)

English

Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

apoptotic process

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

tumour xenograft

1 reference

based on heuristic

inferred from title

author name string

De Cesare M

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Pratesi G

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Giusti A

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Polizzi D

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Zunino F

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

77

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

434-439

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Bcl-2 and the regulation of programmed cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Apoptosis. Its significance in cancer and cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Inactivation of Bcl-2 by phosphorylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Lonidamine: an overview.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

Role and regulation of glucose metabolism in proliferating cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

30 September 2017

The proto-oncogene Bcl-2 and its role in regulating apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

29 June 2018

Inhibition of the recovery from potentially lethal damage by lonidamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

29 June 2018

In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

29 June 2018

Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

29 June 2018

Lonidamine can enhance the cytotoxic effect of cisplatin in human tumour cells and rodent cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

27 July 2018

The role of the glutathione-dependent system in tumor sensitivity to cisplatin: a study of human tumor xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

22 September 2018

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151278

22 September 2018

UKCCCR guidelines for the welfare of animals in experimental neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/9472640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft

1 reference

https://pubmed.ncbi.nlm.nih.gov/9472640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9472640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl2 is the guardian of microtubule integrity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9472640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9472640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9472640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lonidamine-mediated respiratory changes in rat heart myocytes: a re-examination of the functional response of mitochondrial cytochrome c oxidase

1 reference

https://pubmed.ncbi.nlm.nih.gov/9472640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9472640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.69

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36295058&oldid=2198584419"